Article in Marine drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Bei ChenKey Laboratory of Cultivation and High-Value Utilization of Marine Organisms in Fujian Province, National Research and Development Center for Marine Fish Processing, Fisheries Research Institute of Fujian, Xiamen 361013, China.ORCID 0000-0002-9738-7568
Ruowen WuCollege of Chemical Engineering, Hua Qiao University, Xiamen 362021, China.
Kun QiaoKey Laboratory of Cultivation and High-Value Utilization of Marine Organisms in Fujian Province, National Research and Development Center for Marine Fish Processing, Fisheries Research Institute of Fujian, Xiamen 361013, China.ORCID 0000-0002-2372-2837
Kang ChenMimask (Xiamen) Bio-Tech Co., Ltd., Xiamen 361000, China.
Yongchang SuKey Laboratory of Cultivation and High-Value Utilization of Marine Organisms in Fujian Province, National Research and Development Center for Marine Fish Processing, Fisheries Research Institute of Fujian, Xiamen 361013, China.
Shuilin CaiKey Laboratory of Cultivation and High-Value Utilization of Marine Organisms in Fujian Province, National Research and Development Center for Marine Fish Processing, Fisheries Research Institute of Fujian, Xiamen 361013, China.
Min XuKey Laboratory of Cultivation and High-Value Utilization of Marine Organisms in Fujian Province, National Research and Development Center for Marine Fish Processing, Fisheries Research Institute of Fujian, Xiamen 361013, China.ORCID 0009-0006-4379-5749
Shuji LiuKey Laboratory of Cultivation and High-Value Utilization of Marine Organisms in Fujian Province, National Research and Development Center for Marine Fish Processing, Fisheries Research Institute of Fujian, Xiamen 361013, China.ORCID 0000-0001-8058-2730
Zhiyu LiuKey Laboratory of Cultivation and High-Value Utilization of Marine Organisms in Fujian Province, National Research and Development Center for Marine Fish Processing, Fisheries Research Institute of Fujian, Xiamen 361013, China.
Funding
Special Funds Program for High-Quality Development of Marine Services and Fisheries in Fujian Province FJHY-YYKJ-2024-1-4Special Funds Program for Promoting High-Quality Development of the Marine and Fishery Industry in Fujian Province FJHYF-L-2023-22, FJHYF-L-2023-24the Natural Science Foundation of Fujian Province 2023J011324Xiamen Natural Science Foundation Program 3502Z20227304, 3502Z202372087Youth Science and Technology Innovation Program of Xiamen Marine and Fishery Development Special Funds 23YYZP028QCB27
6 · The paper itself
Abstract
Skin sensitivity is increasingly prevalent, necessitating new therapeutic agents. This study screened multifunctional peptides from
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Identification of TRPV1-Inhibitory Peptides from · full record | OpenQuestion